insights_auto
Istiqbol: 36.8% optimistik·10.5% pessimistik
Tahlilga kirishchevron_right
AMGN34:BVMF
Amgen
86,25 R$
0,00%
(0,00) 1K
28-okt, 16:56:00 (GMT-3) · BRL
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoAMGN34 tikeri uchun statistika yaratilmoqda...
Ochish
84,05 R$
Yuqori
86,49 R$
Past
84,05 R$
Bozor kapitali
244,27 mlrd
Oʻrtacha hajm
401,00
Hajmi
1,32 ming
52 haftalik eng yuqori
86,49 R$
52 haftalik eng past
47,76 R$
Muomaladagi aksiyalar
540,63 mln
Xodimlar soni
32 ming
Ochish
84,05 R$
Yuqori
86,49 R$
Past
84,05 R$
Bozor kapitali
244,27 mlrd
Oʻrtacha hajm
401,00
Hajmi
1,32 ming
52 haftalik eng yuqori
86,49 R$
52 haftalik eng past
47,76 R$
Muomaladagi aksiyalar
540,63 mln
Xodimlar soni
32 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Traders Union
·
11 soat oldin
Amgen stock edges higher as Q3 2026 results report date announcement
www.marketscreener.com
·
12 soat oldin
AMGEN ANNOUNCES WEBCAST OF 2026 THIRD QUARTER FINANCIAL RESULTS
Investor's Business Daily
·
1 kun oldin
Dow Jones Biotech Giant Amgen Breaks Out Ahead Of Q3 Earnings Results
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Amgen haqida
CEORobert A. Bradway
Xodimlar soni31,5 ming
Asos solingan1980
Bosh ofislarTauzand-Oks, Kaliforniya, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytamgen.com